For many U.S. IVF patients, especially those traveling to another state or clinic for embryo transfer, the words “PGT-A normal” can feel like the final green light. But before you book flights, arrange time off work, reserve lodging, and schedule medications for a frozen embryo transfer, there is another piece of information that deserves careful attention: the embryo’s morphology grade before and around the time of PGT-A biopsy. Embryo grading is not the same as genetic testing, and it cannot tell whether an embryo has the correct number of chromosomes. However, it can help your care team estimate implantation potential, thaw survival, transfer prioritization, and whether a transfer trip is well timed.
This article explains how embryo grading works before PGT-A, why the grade still matters even when an embryo is reported as euploid, and what questions U.S. IVF patients should ask before scheduling a transfer trip. The goal is not to make patients anxious about letters and numbers, but to help them have a practical, informed conversation with their reproductive endocrinologist and embryology laboratory.
Important medical note: Embryo grading systems vary by laboratory. A “good” grade in one lab may not be directly comparable with the same grade in another lab. PGT-A results, embryo morphology, maternal age, uterine factors, prior pregnancy history, and clinic-specific success rates all need to be interpreted together by your treating physician.
Why embryo grading matters before PGT-A
PGT-A, or preimplantation genetic testing for aneuploidy, is designed to screen embryos for chromosome copy number abnormalities. In most modern IVF laboratories, embryos are grown to the blastocyst stage, a few cells are biopsied from the trophectoderm, and the embryo is vitrified while the testing laboratory analyzes the biopsy sample. The embryo’s appearance is assessed before biopsy, and often again before freezing and after warming.
Embryo grading is a visual assessment of development and structure. It asks: Has the embryo reached the blastocyst stage? How expanded is the fluid-filled cavity? Does the inner cell mass, which may become the fetus, look cohesive and appropriately sized? Does the trophectoderm, which may become the placenta, have a healthy number of cells? These observations are not perfect predictors, but they are clinically useful.
Patients sometimes assume that once an embryo is euploid, its grade no longer matters. In reality, euploidy is extremely important, but morphology still contributes to prognosis. A high-quality euploid blastocyst generally has a higher chance of implantation than a poor-quality euploid blastocyst. A lower-grade euploid embryo can still produce a healthy baby, and many do, but the probability per transfer may be different. For patients traveling for treatment, this distinction matters because each transfer trip involves financial, emotional, and logistical investment.
The basic language of blastocyst grading
Most U.S. IVF laboratories use a version of the Gardner blastocyst grading system, although reporting styles vary. A typical grade may look like 5AA, 4AB, 3BB, or 6BC. The number usually describes the degree of blastocyst expansion. The first letter usually describes the inner cell mass, and the second letter describes the trophectoderm.
| Part of grade | What it generally means | Why patients should care |
|---|---|---|
| Expansion number | How far the blastocyst has expanded, often from early blastocyst to fully hatched. | May influence biopsy timing, freezing readiness, and thaw behavior. |
| First letter: ICM | The appearance of the inner cell mass, the cell group associated with fetal development. | A stronger ICM grade may be associated with better implantation and ongoing pregnancy potential. |
| Second letter: TE | The appearance of the trophectoderm, the outer cell layer associated with placental development. | TE grade is important because biopsy is taken from these cells and may correlate with implantation. |
In many labs, an “A” grade suggests many cells that are tightly organized, a “B” grade suggests moderate or acceptable quality, and a “C” grade suggests fewer cells or less organization. Some labs transfer or freeze C-grade blastocysts; others may have stricter criteria. Some labs use plus and minus signs, such as AB-, BB+, or B/C. Some use numerical scoring rather than classic letters. Because of these variations, patients should ask the clinic how its own grading system is used in decision-making.
Day 5, Day 6, and Day 7 embryos: timing matters
Another important part of embryo evaluation is the day on which the embryo reaches a biopsy-quality blastocyst stage. Many embryos are biopsied on Day 5 or Day 6 after fertilization. Some clinics also biopsy selected Day 7 blastocysts. A Day 5 euploid embryo often has a slightly higher expected implantation potential than a Day 6 euploid embryo of similar morphology, although many Day 6 euploid embryos lead to healthy live births. Day 7 embryos may have lower average implantation rates, but some are still clinically valuable, especially when they are euploid and the patient has limited embryos.
For patients planning travel, the distinction between Day 5, Day 6, and Day 7 can influence transfer prioritization. If you have multiple euploid embryos, your clinic may recommend transferring the best-ranked embryo first based on a combined view of chromosomal status, developmental day, morphology grade, and sometimes other lab observations. If you have only one euploid embryo, the focus shifts from ranking to optimizing the transfer environment and understanding realistic expectations.
| Embryo timing | Common interpretation | Question to ask |
|---|---|---|
| Day 5 blastocyst | Reached blastocyst stage at a typical pace. | Is this embryo the top priority for transfer if euploid? |
| Day 6 blastocyst | Reached blastocyst stage slightly later but may still have strong potential. | How do your clinic’s success rates compare for Day 5 versus Day 6 euploid embryos? |
| Day 7 blastocyst | Later-developing embryo; prognosis varies widely by clinic and grade. | Does your lab biopsy and transfer Day 7 euploid embryos, and what are your outcomes? |
PGT-A does not replace embryo grading
PGT-A answers a genetic screening question; grading answers a developmental and structural question. A euploid embryo has a normal chromosome copy number according to the test performed on the sampled cells. That is very meaningful because aneuploidy is a major cause of implantation failure and miscarriage. But euploidy does not guarantee implantation. Uterine receptivity, embryo metabolism, embryo-endometrium synchrony, transfer technique, lab handling, and chance all play roles.
Likewise, a lower morphology grade does not mean an embryo is “bad” or incapable of producing a baby. Morphology is a snapshot in time. Embryos are dynamic. Some embryos look less organized during a specific observation window but still implant after warming and transfer. However, morphology can help predict average outcomes across groups of patients. That is why clinics often use both PGT-A and morphology to decide which embryo to transfer first.
When you ask about embryo grading before PGT-A, you are not asking for certainty. You are asking for risk stratification. If a clinic tells you, “Your embryo is euploid, so grade does not matter at all,” that may be an oversimplification. If another clinic tells you, “The grade is everything,” that is also incomplete. The most useful counseling usually combines both perspectives.
What to ask before booking a transfer trip
Travel adds complexity to frozen embryo transfer. You may need to coordinate suppression medications, estrogen or natural-cycle monitoring, progesterone start timing, bloodwork, ultrasound appointments, time zones, childcare, work schedules, and post-transfer rest plans. Before locking in travel, patients should confirm not only the PGT-A result but also the embryo’s grade, storage status, and transfer plan.
| Topic | Questions to ask your clinic | Why it matters for travel |
|---|---|---|
| Embryo grade | What was the embryo’s grade at biopsy and at freezing? Was it Day 5, Day 6, or Day 7? | Helps you understand prognosis and transfer prioritization before investing in a trip. |
| PGT-A report | Is the embryo euploid, mosaic, segmental, no-result, or affected by any reporting limitation? | Different result categories may require different counseling, consent, or transfer policies. |
| Thaw survival | What is your lab’s survival rate after warming biopsied and vitrified blastocysts? | Rare thaw failure can disrupt travel plans; backup planning may be needed. |
| Backup embryo | If the selected embryo does not survive warming, is there another embryo available and consented for transfer? | Prevents last-minute cancellation if a backup is appropriate and available. |
| Transfer day logistics | When is the embryo warmed? Will I be notified before arriving? What time should I be in the clinic? | Helps plan same-day transportation and reduces uncertainty. |
Ask for the complete embryo inventory, not just “normal” or “abnormal”
Patients often receive a brief message such as, “You have two normal embryos.” While encouraging, that statement is incomplete for planning. A more useful summary includes the number of embryos biopsied, each embryo’s PGT-A result, day of blastocyst development, morphology grade, sex if you have chosen to receive that information and it is allowed by the clinic, and storage location.
Ask whether the clinic can provide an embryo inventory sheet. This document may include embryo identification numbers, dates of biopsy and vitrification, grades, PGT-A results, and tank/cane location. If you are traveling to a clinic where embryos are already stored, this helps confirm that the embryo selected for transfer is correctly identified. If embryos are being shipped from one facility to another, the inventory becomes even more important.
You should also ask whether grades were assigned before biopsy, after biopsy, before vitrification, after warming, or at multiple time points. A blastocyst may be graded at the time it becomes suitable for biopsy, then collapse after biopsy, then be vitrified. After warming, it may re-expand before transfer. These changes can be normal. Understanding when the grade was recorded prevents confusion when you see different descriptions in different documents.
How clinics rank euploid embryos for transfer
If you have more than one euploid embryo, your clinic will usually recommend an order for transfer. The ranking may consider morphology grade, day of development, expansion stage, ICM grade, TE grade, whether the embryo was fully expanded or hatching, and sometimes patient preferences regarding embryo sex if disclosed and ethically permitted. Some clinics prioritize the best morphology among euploid embryos. Others may prioritize Day 5 over Day 6 when grades are similar. Some give greater weight to the trophectoderm grade, while others consider the inner cell mass more influential.
It is reasonable to ask: “Which embryo would your lab and physician recommend transferring first, and why?” You are not challenging the team; you are asking for transparency. A good answer might sound like: “We recommend embryo 3, a Day 5 4AA euploid blastocyst, because it has the best combination of developmental timing and morphology. Embryo 5 is also euploid but is a Day 6 4BC, so we would keep it as a secondary option.”
If two embryos are similar, the choice may be more flexible. If embryos differ significantly, the lab’s recommendation may be important. For example, a Day 5 4AB and a Day 6 5AA may both be strong candidates, and clinics may differ in which one they prefer. The key is that the choice should be documented before your transfer calendar is finalized.
What if your only euploid embryo has a lower grade?
Many patients panic when they learn their only euploid embryo is graded BC, CB, or CC. It is understandable to feel disappointed, especially after a long IVF process. But lower grade does not mean no chance. Euploid lower-grade embryos can implant and result in live birth. The probability may be lower than that of a top-grade euploid embryo, but it may still be clinically meaningful, particularly if the embryo survived biopsy and vitrification and is considered suitable for transfer by the laboratory.
In this situation, the conversation should focus on optimization and expectations. Ask your physician whether any uterine evaluation is recommended before transfer, such as saline sonogram, hysteroscopy, or review of fibroids, polyps, adhesions, or hydrosalpinx. Ask whether your transfer should be medicated, modified natural, or natural cycle based on your ovulatory pattern and medical history. Ask whether progesterone timing and route have been reviewed carefully. The lower the embryo priority or the fewer embryos available, the more important it becomes to avoid preventable transfer-cycle issues.
You may also want to ask whether the clinic would transfer that embryo if it were their patient’s only euploid embryo, and what live birth rate they quote for similar embryos in their own program. National averages can help, but clinic-specific data are often more relevant because grading standards and lab performance differ.
Mosaic and no-result embryos require special counseling
Not every PGT-A report is simply “normal” or “abnormal.” Some embryos are reported as mosaic, meaning the biopsy sample suggests a mixture of euploid and aneuploid cell lines. Some embryos are reported as segmental abnormalities. Some have no result because the DNA did not amplify or the sample was insufficient. Policies for transferring mosaic or no-result embryos vary widely among U.S. clinics, and they often require additional genetic counseling and consent.
Morphology still matters in these cases, but the genetic counseling layer becomes more complex. If you are considering travel for a mosaic embryo transfer, ask whether the clinic permits it, whether a genetic counselor must review the report, whether prenatal diagnostic testing such as CVS or amniocentesis is recommended if pregnancy occurs, and whether the specific chromosome involved changes the recommendation. Do not schedule a transfer trip for a mosaic or no-result embryo until all approvals are complete.
Ask about the biopsy and freezing process
Embryo grading before PGT-A cannot be separated from the biopsy and vitrification process. A blastocyst must be suitable for biopsy, and the biopsy is usually taken from the trophectoderm. The number of cells removed, the embryo’s expansion stage, the embryologist’s technique, and the lab’s vitrification protocol can all influence post-thaw survival and transfer readiness.
Patients do not need to understand every technical detail, but they should know the lab’s general standards. Ask how many trophectoderm cells are typically biopsied. Ask whether embryos are assisted-hatched before biopsy. Ask whether blastocysts must meet a minimum grade before biopsy and freezing. Ask whether lower-grade embryos are sometimes cultured longer to see if they improve before biopsy. Ask how often biopsied embryos fail to survive warming in that clinic.
Most experienced IVF labs have very high survival rates for vitrified blastocysts, commonly well above 90%, and often higher. Still, “very high” is not “.” If you are flying across the country for transfer, you deserve to know what the lab’s policy is if the embryo does not survive warming or does not re-expand appropriately.
The transfer trip: timing questions that matter
Once the embryo has been selected, the next challenge is synchronizing your endometrium with the embryo. In a programmed frozen embryo transfer, patients commonly use estrogen to build the lining and progesterone to prepare the endometrium. The timing of progesterone exposure must match the embryo stage. For example, a blastocyst transfer is typically scheduled after a specific number of progesterone days, depending on clinic protocol and progesterone route. In a natural or modified natural cycle, transfer is timed relative to ovulation or trigger.
Travel patients should ask exactly when they need to arrive. Some clinics want patients in town one or two days before transfer. Others allow arrival the evening before, assuming monitoring has been completed locally. Ask whether lining checks and bloodwork can be done near home, which labs are acceptable, how quickly results must be received, and who is responsible for reviewing them. Ask what happens if your lining is too thin, progesterone is unexpectedly high or low, ovulation occurs early, or medication shipment is delayed.
It is also wise to ask whether the clinic recommends staying in town after transfer. Medically, many patients can travel soon after embryo transfer, including by car or plane, but individual situations differ. Some patients prefer to stay overnight for comfort and reduced stress. Others return home the same day. Your clinic can advise based on your procedure time, sedation policy if any, distance, and medical history.
Questions about success rates: ask for relevant numbers
When discussing embryo grading and PGT-A, patients often ask, “What is my chance?” The most honest answer is usually a range. Success depends on embryo factors, uterine factors, patient history, and clinic performance. Still, you can ask for the most relevant data rather than accepting a broad clinic-wide statistic.
Useful questions include: What is your live birth rate per transfer for euploid embryos in my age group? Do you separate outcomes by embryo grade? Do Day 5 and Day 6 euploid embryos have different outcomes in your program? How do lower-grade euploid embryos perform? What is the miscarriage rate after euploid transfer? What percentage of transfers are canceled after the patient starts medication, and why?
Be cautious when comparing clinics using advertised success rates. Some clinics transfer only top-quality embryos, while others accept more complex cases. Some have strict embryo selection policies, while others may transfer lower-grade, mosaic, or Day 7 embryos after counseling. A clinic with broader transfer criteria may appear to have lower average rates but may be serving a more complex patient population. Ask for context.
Embryo shipping and chain of custody
If your embryos were created at one clinic but you plan to transfer at another, embryo shipping introduces additional steps. Before scheduling a transfer trip, confirm that the receiving clinic has accepted the embryos, reviewed the records, verified infectious disease testing requirements, and confirmed that the embryos are stored onsite. Do not assume that a transfer can be scheduled immediately after shipment. Some clinics require a record review and lab approval before creating a transfer calendar.
Ask whether the receiving lab agrees with the outside lab’s grading or whether it will only assess the embryo after warming. Because frozen embryos cannot be regraded in the same way until thawed, the receiving clinic often relies on the original records. If documentation is incomplete, the receiving team may have limited ability to counsel you about prognosis. Make sure the PGT-A report, biopsy date, embryo grade, embryo ID, and cryostorage details are all available.
Chain of custody is also essential. Clinics use strict identification systems, consent forms, witness procedures, and labeling protocols. Patients should ensure that all names, dates of birth, embryo IDs, and consent documents match exactly. Small administrative errors can delay a transfer cycle, especially for travel patients with narrow scheduling windows.
A practical checklist before you buy tickets
| Confirm before travel | What you should have in writing |
|---|---|
| Embryo selected | Embryo ID, PGT-A result, day of development, morphology grade, and priority order. |
| Consent completed | Transfer consent, thaw consent, disposition choices if required, and any genetic counseling documentation. |
| Medication calendar | Start dates, dose changes, progesterone timing, and backup plan for delayed medication delivery. |
| Monitoring plan | Where ultrasounds and bloodwork will be performed, deadlines for results, and cancellation criteria. |
| Travel timing | Arrival date, transfer time estimate, whether a full bladder is required, and when you may travel home. |
| Contingency plan | What happens if lining is not ready, labs are abnormal, embryo does not survive warming, or weather disrupts travel. |
Common misunderstandings to clear up
“A euploid embryo always works.” Unfortunately, no. Euploid embryos have a much better chance than untested embryos of unknown chromosomal status, but implantation is not guaranteed.
“A poor-grade embryo cannot become a healthy baby.” Also not true. Lower-grade euploid embryos can result in healthy live births. Grade affects probability, not destiny.
“Embryo grading is objective and identical everywhere.” Grading has subjective elements. Embryologists are highly trained, but lab standards and reporting practices vary.
“The biopsy grade and transfer-day appearance are the same thing.” Not necessarily. Embryos often collapse after biopsy and vitrification, then re-expand after warming. Your clinic may assess survival and re-expansion on transfer day.
“If the embryo is hatching or hatched, it is always better.” Hatching can be a sign of advanced development, but interpretation depends on the embryo’s full grade, day, biopsy status, and lab context.
How to communicate with your clinic effectively
When you contact your clinic, it helps to be specific and organized. Instead of asking, “Are my embryos good?” ask: “Can you provide the day, grade, PGT-A result, and recommended transfer order for each embryo?” Instead of asking, “Will this work?” ask: “Based on your clinic’s outcomes, what is the estimated live birth rate for a euploid embryo with this grade and day of development?”
If you are working with a nurse coordinator, ask whether the embryologist or physician can add interpretation. Nurses are central to IVF care and often manage calendars, medications, and instructions, but embryo grading questions may require laboratory input. A short written explanation from the lab can prevent misunderstanding.
If you feel overwhelmed, request a pre-transfer consultation before travel. This is especially valuable if you have only one embryo, a lower-grade embryo, a mosaic result, recurrent implantation failure, recurrent pregnancy loss, a history of uterine surgery, thin lining, adenomyosis, endometriosis, or immune/medical conditions that may affect pregnancy planning.
A patient-friendly script
“Before I finalize travel for my frozen embryo transfer, I would like to confirm the embryo details. Can you please tell me the embryo ID, day of blastocyst development, morphology grade at biopsy or freezing, PGT-A result category, and whether this is the embryo your lab recommends transferring first? Also, what is your policy if the embryo does not survive warming, and do I have a backup embryo available and consented? Finally, based on your clinic’s data, what success rate range would you quote for an embryo with this grade and result?”
The bottom line
Embryo grading before PGT-A is not just a laboratory detail. It is part of the decision-making framework that helps patients and clinics choose which embryo to transfer, estimate the chance of success, prepare for thaw and transfer, and avoid preventable travel disruptions. For U.S. IVF patients planning a transfer trip, asking about embryo grade is not being difficult or overly technical. It is responsible planning.
The best pre-transfer counseling combines genetic information, morphology, embryo development timing, lab performance, uterine preparation, and patient-specific history. A euploid result is excellent news, but it should be interpreted alongside the embryo’s day and grade. A lower-grade euploid embryo may still be worth transferring, but patients should understand the expected prognosis and contingency plan before they book flights.
Before scheduling your trip, make sure you can answer these core questions: Which embryo is being transferred? What was its grade and developmental day? What exactly did PGT-A show? What is the clinic’s thaw survival experience? What happens if the cycle or embryo does not proceed as planned? When those answers are clear, your transfer trip can be organized with more confidence, less confusion, and a stronger partnership between you and your fertility team.
